Elaine Blais

Popular Topics

Intellectual Property

DETAILS

United States

www.goodwinlaw.com

+1 617 5701000

AUTHORS CONTENT

Proposed BPCIA Reform Legislation Likely To Have Little Effect Even If Passed

United States IP

Amgen Files BPCIA Complaint Against Samsung Bioepsis Regarding Denosumab

United States IP

GSK Sues Pfizer, Pharmacia & Upjohn & BioNTech For Infringing MRNA Vaccine Patents

United States IP

REGENXBIO And Sarepta Agree To Stay Litigation Pending Outcome Of Sarepta's IPR Petition

United States IP

Goodwin Releases Update To Its Comprehensive Guide To Biosimilars Litigation And Regulation In The U.S.

United States IP

Genentech Files BPCIA Complaint Against Biogen Regarding Tocilizumab

United States IP

Coherus And AbbVie File Dueling Motions For Injunctive Relief Relating To Coherus's HUMIRA Biosimilar

United States Healthcare

Update On Arbutus MRNA Vaccine Patent Litigations

United States IP

Year In Review: Top Deals In 2022

United States Commercial

Year In Review: Top Legal Developments Of 2022

United States IP

AWARDS

Autumn 2022 Award for Antitrust/Competition Law in United States

Antitrust/Competition Law

Regeneron Files Antitrust Lawsuit Accusing Amgen Of Engaging In A Persistent Exclusionary Campaign To Deny Patients Access To Praluent®

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More